Tropicamide/Phenylephrine/Lidocaine Intracameral Injection: A Review in Cataract Surgery.
Adult
Aged
Aged, 80 and over
Cataract
/ diagnosis
Cataract Extraction
/ methods
Drug Combinations
Drug Therapy, Combination
Female
Humans
Injections
Lidocaine
/ administration & dosage
Male
Middle Aged
Mydriatics
/ administration & dosage
Phacoemulsification
/ methods
Phenylephrine
/ administration & dosage
Prospective Studies
Pupil
/ drug effects
Tropicamide
/ administration & dosage
Journal
Clinical drug investigation
ISSN: 1179-1918
Titre abrégé: Clin Drug Investig
Pays: New Zealand
ID NLM: 9504817
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
pubmed:
1
9
2019
medline:
7
1
2020
entrez:
1
9
2019
Statut:
ppublish
Résumé
Tropicamide 0.02%/phenylephrine 0.31%/lidocaine 1% injectable solution (Mydrane
Identifiants
pubmed: 31471864
doi: 10.1007/s40261-019-00843-z
pii: 10.1007/s40261-019-00843-z
doi:
Substances chimiques
Drug Combinations
0
Mydriatics
0
phenylephrine, lidocaine drug combination
0
Phenylephrine
1WS297W6MV
Lidocaine
98PI200987
Tropicamide
N0A3Z5XTC6
Types de publication
Clinical Trial, Phase III
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1133-1139Références
World Health Organization. Blindness and vision impairment prevention: priority eye diseases. Cataract. 2019. https://www.who.int/blindness/causes/priority/en/index1.html . Accessed 5 Aug 2019.
Lam D, Rao SK, Ratra V, et al. Cataract. Nat Rev Dis Primers. 2015;1:15014.
pubmed: 27188414
doi: 10.1038/nrdp.2015.14
Srinivasan S. Intracameral mydriatics during cataract surgery. J Cataract Refract Surg. 2018;44(3):257–8.
pubmed: 29703282
doi: 10.1016/j.jcrs.2018.03.007
Mamalis N. Importance of pupil dilation for cataract surgery. J Cataract Refract Surg. 2017;43(5):583–4.
pubmed: 28602315
doi: 10.1016/j.jcrs.2017.05.018
Grob SR, Gonzalez-Gonzalez LA, Daly MK. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions. Clin Ophthalmol. 2014;8:1281–9.
pubmed: 25061276
pmcid: 4086849
Devgan U. Ocular anesthesia renders better, safer cataract surgery; 2012. https://www.healio.com/ophthalmology/cataract-surgery/news/ . Accessed 5 Aug 2019.
Stavert B, McGuinness MB, Harper CA, et al. Cardiovascular adverse effects of phenylephrine eyedrops: a systematic review and meta-analysis. JAMA Ophthalmol. 2015;133(6):647–52.
pubmed: 25789577
doi: 10.1001/jamaophthalmol.2015.0325
Thea Pharmaceuticals Ltd. Mydrane: summary of product characteristics; 2019. https://www.medicines.org.uk/emc/product/7254/smpc . Accessed 5 Aug 2019.
Nikeghbali A, Falavarjani KG, Kheirkhah A. Pupil dilation with intracameral lidocaine during phacoemulsification: benefits for the patient and surgeon. Indian J Ophthalmol. 2008;56(1):63–4.
pubmed: 18158406
pmcid: 2636064
doi: 10.4103/0301-4738.37598
Chiambaretta F, Pleyer U, Behndig A, et al. Pupil dilation dynamics with an intracameral fixed combination of mydriatics and anesthetic during cataract surgery. J Cataract Refract Surg. 2018;44(3):341–7.
pubmed: 29703287
doi: 10.1016/j.jcrs.2017.12.025
Khoo L, Srinivasan S. Real-world experience with the first commercially available intracameral mydriatic and anaesthetic during cataract surgery [abstract]. In: 36th Congress of the ESCRS; 2018.
Labetoulle M, Findl O, Malecaze F, et al. Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery. Br J Ophthalmol. 2016;100(7):976–85.
pubmed: 26531052
doi: 10.1136/bjophthalmol-2015-307587
Gain P, Crouzet E, Khatib W, et al. Corneal endothelial follow-up after intracameral injection of lidocaine, tropicamide and phenylephrine for mydriasis during cataract surgery [abstract S018]. Acta Ophthalmol. 2018;96(Suppl 261):41.
Nuijts RM, Mencucci R, Viaud-Quentric K, et al. Ocular tolerance in rabbits after intracameral administration of a fixed combination of tropicamide, phenylephrine, and lidocaine with and without rinsing. J Cataract Refract Surg. 2017;43(5):673–9.
pubmed: 28602331
doi: 10.1016/j.jcrs.2017.03.025
Guell J, Behndig A, Pleyer U, et al. Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. Clin Ophthalmol. 2019;13:811–9.
pubmed: 31118559
pmcid: 6501990
doi: 10.2147/OPTH.S189671
Patel J-H, Thethy J, Aggarwal K, et al. Mydrane™ for high volume cataract surgery. J Ophthalmol Surg. 2017;1(1):1–6.
Schulz CB, Goverdhan SV, Humphry RC. An evaluation of intracameral mydriasis for routine cataract surgery. Br J Ophthalmol. 2018;102(6):784–9.
pubmed: 28903962
doi: 10.1136/bjophthalmol-2017-310510
Labetoulle M, Rousseau A, Barreau E, et al. Retrospective assessment of the use of ICMA in a routine setting for patients undergoing cataract surgery in south Paris university hospital [abstract]. In: 23rd Winter Meeting of the ESCRS; 2019.
Labetoulle M. Efficacy and safety of intracameral administration of a fixed combination of mydriatics and anesthetics during cataract surgery in type II diabetic patients [abstract]. In: 36th Congress of the ESCRS; 2018.
Davey K, Chang B, Purslow C, et al. Budget impact model of Mydrane
Thea Laboratories. Mydriasert 0.28 mg/5.4 mg ophthalmic insert: summary of product characteristics; 2019. https://www.medicines.org.uk/ . Accessed 5 Aug 2019.
Omeros Ireland Ltd. Omidria 10 mg/mL + 3 mg/mL concentrate for solution for intraocular irrigation: summary of product characteristics; 2019. https://www.ema.europa.eu . Accessed 5 Aug 2019.